Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2012

Open Access 01-10-2012 | Research article

Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis

Authors: Janet Wohlers, Katrin Breucker, Rainer Podschun, Jürgen Hedderich, Peter Lamprecht, Petra Ambrosch, Martin Laudien

Published in: Arthritis Research & Therapy | Issue 5/2012

Login to get access

Abstract

Introduction

In granulomatosis with polyangiitis (GPA), a complex autoimmune small-vessel vasculitis frequently associated with chronic necrotizing inflammation of the nasal mucosa, elevated nasal Staphylococcus (S.) aureus carrier rates are a risk factor for relapse. As cytokines are primarily involved in the regulation of defense against potentially pathogenic microorganisms, the aim of this study was to compare healthy individuals and GPA patients with respect to their baseline cytokine expression of nasal epithelial cells (NEC), which form the first barrier against such triggers. The ability of S. aureus to influence the nasal microenvironment's cytokine secretion was assessed by exemplary stimulation experiments.

Methods

Baseline expression of 19 cytokines of primary NEC of GPA patients and normal controls (NC) was quantified by a multiplex cytokine assay. Stimulation experiments were performed with supernatants of S. aureus and expression of interleukin-8 was determined by ELISA.

Results

In GPA, an altered pattern of baseline cytokine expression with significantly up-regulated G-CSF and reduced interleukin (IL)-8 concentrations was observed. Both NEC of GPA patients and NC responded to stimulation with S. aureus, but GPA patients displayed a significantly lower IL-8 secretion and a diminished dynamic range of response towards the stimulus.

Conclusions

The data presented underline the hypothesis of a disturbed epithelial nasal barrier function in GPA. The dysregulated baseline expression of G-CSF and IL-8 and the reduced response to microbial stimulation may facilitate changes in the composition of the nasal flora and favour an imbalanced inflammatory response, which might be relevant for the disease course.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bacon PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med. 2005, 352: 330-332.CrossRefPubMed Bacon PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med. 2005, 352: 330-332.CrossRefPubMed
2.
go back to reference Paulsen JI, Rudert H: Manifestations of primary vasculitis in the ENT region. Z Rheumatol. 2001, 60: 219-225.CrossRefPubMed Paulsen JI, Rudert H: Manifestations of primary vasculitis in the ENT region. Z Rheumatol. 2001, 60: 219-225.CrossRefPubMed
3.
go back to reference Hamidou MA, Audrain M, Ninin E, Robillard N, Muller JY, Bonneville M: Staphylococcus aureus, T-cell repertoire, and Wegener's granulomatosis. Joint Bone Spine. 2001, 68: 373-377.CrossRefPubMed Hamidou MA, Audrain M, Ninin E, Robillard N, Muller JY, Bonneville M: Staphylococcus aureus, T-cell repertoire, and Wegener's granulomatosis. Joint Bone Spine. 2001, 68: 373-377.CrossRefPubMed
4.
go back to reference Jagiello P, Gross WL, Epplen JT: Complex genetics of Wegener granulomatosis. Autoimmun Rev. 2005, 4: 42-47.CrossRefPubMed Jagiello P, Gross WL, Epplen JT: Complex genetics of Wegener granulomatosis. Autoimmun Rev. 2005, 4: 42-47.CrossRefPubMed
5.
go back to reference Laudien M, Ambrosch P, Till A, Podschun R, Lamprecht P: [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement]. Z Rheumatol. 2008, 67: 397-406.PubMed Laudien M, Ambrosch P, Till A, Podschun R, Lamprecht P: [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement]. Z Rheumatol. 2008, 67: 397-406.PubMed
6.
go back to reference Tervaert JW, Popa ER, Bos NA: The role of superantigens in vasculitis. Curr Opin Rheumatol. 1999, 11: 24-33.CrossRefPubMed Tervaert JW, Popa ER, Bos NA: The role of superantigens in vasculitis. Curr Opin Rheumatol. 1999, 11: 24-33.CrossRefPubMed
7.
go back to reference Wieczorek S, Holle JU, Epplen JT: Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome. Curr Opin Rheumatol. 2010, 22: 8-14.CrossRefPubMed Wieczorek S, Holle JU, Epplen JT: Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome. Curr Opin Rheumatol. 2010, 22: 8-14.CrossRefPubMed
8.
go back to reference Laudien M, Gadola SD, Podschun R, Hedderich J, Paulsen J, Reinhold-Keller E, Csernok E, Ambrosch P, Hellmich B, Moosig F, Gross WL, Sahly H, Lamprecht P: Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol. 2010, 28: 51-55.PubMed Laudien M, Gadola SD, Podschun R, Hedderich J, Paulsen J, Reinhold-Keller E, Csernok E, Ambrosch P, Hellmich B, Moosig F, Gross WL, Sahly H, Lamprecht P: Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol. 2010, 28: 51-55.PubMed
9.
go back to reference Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, De Jong PE, Kallenberg CG: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994, 120: 12-17.CrossRefPubMed Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, De Jong PE, Kallenberg CG: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994, 120: 12-17.CrossRefPubMed
10.
go back to reference Stegeman CA, Tervaert JW, De Jong PE, Kallenberg CG: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996, 335: 16-20.CrossRefPubMed Stegeman CA, Tervaert JW, De Jong PE, Kallenberg CG: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996, 335: 16-20.CrossRefPubMed
11.
go back to reference Popa ER, Stegeman CA, Abdulahad WH, van der Meer B, Arends J, Manson WM, Bos NA, Kallenberg CG, Cohen Tervaert JW: Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology (Oxford). 2007, 46: 1029-1033.CrossRef Popa ER, Stegeman CA, Abdulahad WH, van der Meer B, Arends J, Manson WM, Bos NA, Kallenberg CG, Cohen Tervaert JW: Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology (Oxford). 2007, 46: 1029-1033.CrossRef
12.
go back to reference Zycinska K, Wardyn KA, Zielonka TM, Demkow U, Traburzynski MS: Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis. J Physiol Pharmacol. 2008, 59 (Suppl 6): 825-831.PubMed Zycinska K, Wardyn KA, Zielonka TM, Demkow U, Traburzynski MS: Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis. J Physiol Pharmacol. 2008, 59 (Suppl 6): 825-831.PubMed
13.
go back to reference De Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nolle B, Gross WL: Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum. 1996, 39: 2052-2061.CrossRefPubMed De Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nolle B, Gross WL: Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum. 1996, 39: 2052-2061.CrossRefPubMed
14.
go back to reference Reinhold-Keller E, de Groot K, Rudert H, Nölle B, Heller M, Gross WL: Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. QJM. 1996, 89: 15-23.CrossRefPubMed Reinhold-Keller E, de Groot K, Rudert H, Nölle B, Heller M, Gross WL: Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. QJM. 1996, 89: 15-23.CrossRefPubMed
16.
go back to reference Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG: CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann N Y Acad Sci. 2007, 1107: 22-31.CrossRefPubMed Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG: CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann N Y Acad Sci. 2007, 1107: 22-31.CrossRefPubMed
17.
go back to reference Mayet WJ, Marker-Hermann E, Schlaak J, Meyer Zum Büschenfelde KH: Irregular cytokine pattern of CD4+ T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis. Scand J Immunol. 1999, 49: 585-594.CrossRefPubMed Mayet WJ, Marker-Hermann E, Schlaak J, Meyer Zum Büschenfelde KH: Irregular cytokine pattern of CD4+ T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis. Scand J Immunol. 1999, 49: 585-594.CrossRefPubMed
18.
go back to reference Laudien M, Häsler R, Wohlers J, Böck J, Lipinski S, Bremer L, Podschun R, Ambrosch P, Lamprecht P, Rosenstiel P, Till A: Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunol. 2011, 4: 564-573.CrossRefPubMed Laudien M, Häsler R, Wohlers J, Böck J, Lipinski S, Bremer L, Podschun R, Ambrosch P, Lamprecht P, Rosenstiel P, Till A: Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunol. 2011, 4: 564-573.CrossRefPubMed
19.
go back to reference Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D: Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008, 14: 1088-1096.PubMedCentralCrossRefPubMed Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D: Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008, 14: 1088-1096.PubMedCentralCrossRefPubMed
20.
go back to reference Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, Falk RJ: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004, 10: 72-79.CrossRefPubMed Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, Falk RJ: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004, 10: 72-79.CrossRefPubMed
21.
23.
go back to reference Csernok E, Szymkowiak CH, Mistry N, Daha MR, Gross WL, Kekow J: Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol. 1996, 105: 104-111.PubMedCentralCrossRefPubMed Csernok E, Szymkowiak CH, Mistry N, Daha MR, Gross WL, Kekow J: Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol. 1996, 105: 104-111.PubMedCentralCrossRefPubMed
24.
go back to reference Krumbholz M, Specks U, Wick M, Kalled SL, Jenne D, Meinl E: BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun. 2005, 25: 298-302.CrossRefPubMed Krumbholz M, Specks U, Wick M, Kalled SL, Jenne D, Meinl E: BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun. 2005, 25: 298-302.CrossRefPubMed
25.
go back to reference Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Froland SS: Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro. Clin Exp Immunol. 2005, 140: 376-383.PubMedCentralCrossRefPubMed Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Froland SS: Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro. Clin Exp Immunol. 2005, 140: 376-383.PubMedCentralCrossRefPubMed
26.
go back to reference Lamprecht P, Kumanovics G, Mueller A, Csernok E, Komocsi A, Trabandt A, Gross WL, Schnabel A: Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clin Exp Immunol. 2002, 128: 181-186.PubMedCentralCrossRefPubMed Lamprecht P, Kumanovics G, Mueller A, Csernok E, Komocsi A, Trabandt A, Gross WL, Schnabel A: Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clin Exp Immunol. 2002, 128: 181-186.PubMedCentralCrossRefPubMed
27.
go back to reference Ludviksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, Fauci AS, Strober W: Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol. 1998, 160: 3602-3609.PubMed Ludviksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, Fauci AS, Strober W: Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol. 1998, 160: 3602-3609.PubMed
28.
go back to reference Coulomb-L'Hermine A, Capron F, Zou W, Piard F, Galateau F, Laurent P, Crevon MC, Galanaud P, Emilie D: Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis. Hum Pathol. 2001, 32: 320-326.CrossRefPubMed Coulomb-L'Hermine A, Capron F, Zou W, Piard F, Galateau F, Laurent P, Crevon MC, Galanaud P, Emilie D: Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis. Hum Pathol. 2001, 32: 320-326.CrossRefPubMed
29.
go back to reference Zhou Y, Huang D, Farver C, Hoffman GS: Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J Rheumatol. 2003, 30: 1541-1547.PubMed Zhou Y, Huang D, Farver C, Hoffman GS: Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J Rheumatol. 2003, 30: 1541-1547.PubMed
30.
go back to reference Richter AG, Stockley RA, Harper L, Thickett DR: Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis. Thorax. 2009, 64: 692-697.CrossRefPubMed Richter AG, Stockley RA, Harper L, Thickett DR: Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis. Thorax. 2009, 64: 692-697.CrossRefPubMed
31.
go back to reference Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007, 66: 605-617.PubMedCentralCrossRefPubMed Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007, 66: 605-617.PubMedCentralCrossRefPubMed
32.
go back to reference Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL: Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum. 1994, 37: 919-924.CrossRefPubMed Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL: Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum. 1994, 37: 919-924.CrossRefPubMed
33.
go back to reference Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994, 87: 671-678.PubMed Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994, 87: 671-678.PubMed
34.
go back to reference Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D: Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997, 40: 371-380.CrossRefPubMed Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D: Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997, 40: 371-380.CrossRefPubMed
35.
go back to reference Luqmani RA: Assessing disease activity in the systemic vasculitides. Curr Opin Rheumatol. 2002, 14: 23-28.CrossRefPubMed Luqmani RA: Assessing disease activity in the systemic vasculitides. Curr Opin Rheumatol. 2002, 14: 23-28.CrossRefPubMed
36.
go back to reference Reinhold-Keller E, Beuge N, Latza U, De Groot K, Rudert H, Nolle B, Heller M, Gross WL: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000, 43: 1021-1032.CrossRefPubMed Reinhold-Keller E, Beuge N, Latza U, De Groot K, Rudert H, Nolle B, Heller M, Gross WL: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000, 43: 1021-1032.CrossRefPubMed
37.
go back to reference Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983, 98: 76-85.CrossRefPubMed Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983, 98: 76-85.CrossRefPubMed
38.
go back to reference Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A: International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999, 111: 507-513.PubMed Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A: International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999, 111: 507-513.PubMed
39.
go back to reference Holtfreter S, Grumann D, Schmudde M, Nguyen HT, Eichler P, Strommenger B, Kopron K, Kolata J, Giedrys-Kalemba S, Steinmetz I, Witte W, Broker BM: Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol. 2007, 45: 2669-2680.PubMedCentralCrossRefPubMed Holtfreter S, Grumann D, Schmudde M, Nguyen HT, Eichler P, Strommenger B, Kopron K, Kolata J, Giedrys-Kalemba S, Steinmetz I, Witte W, Broker BM: Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol. 2007, 45: 2669-2680.PubMedCentralCrossRefPubMed
40.
go back to reference Sachse F, von Eiff C, Stoll W, Becker K, Rudack C: Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitis. Clin Exp Immunol. 2006, 144: 534-542.PubMedCentralCrossRefPubMed Sachse F, von Eiff C, Stoll W, Becker K, Rudack C: Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitis. Clin Exp Immunol. 2006, 144: 534-542.PubMedCentralCrossRefPubMed
41.
go back to reference Balding CE, Howie AJ, Drake-Lee AB, Savage CO: Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol. 2001, 125: 332-339.PubMedCentralCrossRefPubMed Balding CE, Howie AJ, Drake-Lee AB, Savage CO: Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol. 2001, 125: 332-339.PubMedCentralCrossRefPubMed
42.
go back to reference Eyles JL, Roberts AW, Metcalf D, Wicks IP: Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol. 2006, 2: 500-510.CrossRefPubMed Eyles JL, Roberts AW, Metcalf D, Wicks IP: Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol. 2006, 2: 500-510.CrossRefPubMed
43.
go back to reference Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima M: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990, 76: 1962-1964.PubMed Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima M: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990, 76: 1962-1964.PubMed
44.
go back to reference Kawakami T, Ohashi S, Kawa Y, Takahama H, Ito M, Soma Y, Mizoguchi M: Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004, 140: 570-574.CrossRefPubMed Kawakami T, Ohashi S, Kawa Y, Takahama H, Ito M, Soma Y, Mizoguchi M: Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004, 140: 570-574.CrossRefPubMed
45.
go back to reference Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, Tominaga T, Tominaga M, Eguchi K: High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2000, 18: 713-718.PubMed Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, Tominaga T, Tominaga M, Eguchi K: High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2000, 18: 713-718.PubMed
46.
go back to reference Ina K, Kusugami K, Hosokawa T, Imada A, Shimizu T, Yamaguchi T, Ohsuga M, Kyokane K, Sakai T, Nishio Y, Yokoyama Y, Ando T: Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in inflammatory bowel disease. J Gastroenterol Hepatol. 1999, 14: 46-53.CrossRefPubMed Ina K, Kusugami K, Hosokawa T, Imada A, Shimizu T, Yamaguchi T, Ohsuga M, Kyokane K, Sakai T, Nishio Y, Yokoyama Y, Ando T: Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in inflammatory bowel disease. J Gastroenterol Hepatol. 1999, 14: 46-53.CrossRefPubMed
47.
go back to reference Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW: Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 2002, 99: 672-679.CrossRefPubMed Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW: Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 2002, 99: 672-679.CrossRefPubMed
48.
go back to reference Hellmich B, Csernok E, Trabandt A, Gross WL, Ernst M: Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin Exp Immunol. 2000, 120: 392-398.PubMedCentralCrossRefPubMed Hellmich B, Csernok E, Trabandt A, Gross WL, Ernst M: Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin Exp Immunol. 2000, 120: 392-398.PubMedCentralCrossRefPubMed
49.
go back to reference Kallenberg CG, Stegeman CA, Heeringa P: Autoantibodies vex the vasculature. Nat Med. 2008, 14: 1018-1019.CrossRefPubMed Kallenberg CG, Stegeman CA, Heeringa P: Autoantibodies vex the vasculature. Nat Med. 2008, 14: 1018-1019.CrossRefPubMed
50.
go back to reference Schneider EM, Lorenz I, Ma X, Weiss M: G-CSF modulates LPS-induced apoptosis and IL-8 in human microvascular endothelial cells: involvement of calcium signaling. Ann N Y Acad Sci. 2003, 1010: 78-85.CrossRefPubMed Schneider EM, Lorenz I, Ma X, Weiss M: G-CSF modulates LPS-induced apoptosis and IL-8 in human microvascular endothelial cells: involvement of calcium signaling. Ann N Y Acad Sci. 2003, 1010: 78-85.CrossRefPubMed
51.
go back to reference Leavey PJ, Sellins KS, Thurman G, Elzi D, Hiester A, Silliman CC, Zerbe G, Cohen JJ, Ambruso DR: In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood. 1998, 92: 4366-4374.PubMed Leavey PJ, Sellins KS, Thurman G, Elzi D, Hiester A, Silliman CC, Zerbe G, Cohen JJ, Ambruso DR: In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood. 1998, 92: 4366-4374.PubMed
52.
go back to reference Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA: Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009, 84: 353-360.CrossRefPubMed Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA: Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009, 84: 353-360.CrossRefPubMed
53.
go back to reference Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol. 1994, 95: 244-250.PubMedCentralCrossRefPubMed Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol. 1994, 95: 244-250.PubMedCentralCrossRefPubMed
54.
go back to reference Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, Weening JJ, Kallenberg CG: Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 1994, 45: 1120-1131.CrossRefPubMed Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, Weening JJ, Kallenberg CG: Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 1994, 45: 1120-1131.CrossRefPubMed
55.
go back to reference Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002, 72: 847-855.PubMed Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002, 72: 847-855.PubMed
56.
go back to reference Damm M, Quante G, Rosenbohm J, Rieckmann R: Proinflammatory effects of Staphylococcus aureus exotoxin B on nasal epithelial cells. Otolaryngol Head Neck Surg. 2006, 134: 245-249.CrossRefPubMed Damm M, Quante G, Rosenbohm J, Rieckmann R: Proinflammatory effects of Staphylococcus aureus exotoxin B on nasal epithelial cells. Otolaryngol Head Neck Surg. 2006, 134: 245-249.CrossRefPubMed
57.
go back to reference Rudack C, Sachse F, Albert N, Becker K, von Eiff C: Immunomodulation of nasal epithelial cells by Staphylococcus aureus-derived serine proteases. J Immunol. 2009, 183: 7592-7601.CrossRefPubMed Rudack C, Sachse F, Albert N, Becker K, von Eiff C: Immunomodulation of nasal epithelial cells by Staphylococcus aureus-derived serine proteases. J Immunol. 2009, 183: 7592-7601.CrossRefPubMed
58.
go back to reference Ullrich S, Gustke H, Lamprecht P, Gross WL, Schumacher U, Ambrosch P, Laudien M: Severely impaired respiratory ciliar function in Wegener's granulomatosis. Ann Rheum Dis. 2008, 68: 1067-1071.CrossRefPubMed Ullrich S, Gustke H, Lamprecht P, Gross WL, Schumacher U, Ambrosch P, Laudien M: Severely impaired respiratory ciliar function in Wegener's granulomatosis. Ann Rheum Dis. 2008, 68: 1067-1071.CrossRefPubMed
59.
go back to reference Hui Y, Wohlers J, Podschun R, Hedderich J, Lamprecht P, Ambrosch P, Laudien M: Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonization in Wegener's granulomatosis. Clin Exp Rheumatol. 2011, 29: 49-56. Hui Y, Wohlers J, Podschun R, Hedderich J, Lamprecht P, Ambrosch P, Laudien M: Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonization in Wegener's granulomatosis. Clin Exp Rheumatol. 2011, 29: 49-56.
60.
61.
go back to reference Sachse F, von Eiff C, Becker K, Rudack C: Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. J Inflamm (Lond). 2008, 5: 11-CrossRef Sachse F, von Eiff C, Becker K, Rudack C: Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. J Inflamm (Lond). 2008, 5: 11-CrossRef
62.
go back to reference Szekanecz Z, Vegvari A, Szabo Z, Koch AE: Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed). 2010, 2: 153-167.CrossRef Szekanecz Z, Vegvari A, Szabo Z, Koch AE: Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed). 2010, 2: 153-167.CrossRef
63.
go back to reference Zwierzina H, Holzinger I, Gaggl S, Wolf H, Schollenberger S, Lam C, Bammer T, Geissler D, Lindley I: Recombinant human interleukin-8 restores function in neutrophils from patients with myelodysplastic syndromes without stimulating myeloid progenitor cells. Scand J Immunol. 1993, 37: 322-328.CrossRefPubMed Zwierzina H, Holzinger I, Gaggl S, Wolf H, Schollenberger S, Lam C, Bammer T, Geissler D, Lindley I: Recombinant human interleukin-8 restores function in neutrophils from patients with myelodysplastic syndromes without stimulating myeloid progenitor cells. Scand J Immunol. 1993, 37: 322-328.CrossRefPubMed
64.
go back to reference Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y: Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010, 465: 346-349.CrossRefPubMed Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y: Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010, 465: 346-349.CrossRefPubMed
Metadata
Title
Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis
Authors
Janet Wohlers
Katrin Breucker
Rainer Podschun
Jürgen Hedderich
Peter Lamprecht
Petra Ambrosch
Martin Laudien
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4041

Other articles of this Issue 5/2012

Arthritis Research & Therapy 5/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.